Dr. Benjamin David Ehst, MD, PhD

Dr. Ehst practices at The Oregon Clinic Broadway Medical in Portland, Oregon.

Dr. Ehst's NPI, 1740320068, was assigned on February 7, 2007. Dr. Ehst graduated from University of Minnesota Medical School in 2003. Dr. Ehst holds Oregon license MD27612.

Dr. Ehst's primary practice is The Oregon Clinic Broadway Medical, at 4212 N.E. Broadway, Portland, OR 97213. The practice phone is (503) 331-7646.

Dr. Ehst's primary practice is The Oregon Clinic Broadway Medical in Portland, Oregon. The medical group on file is The Oregon Clinic Broadway Medical. Dmand AI also links Dr. Ehst to 1 more group practice or clinic, named with a free account. Dr. Ehst's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ehst practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ehst's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ehst is licensed in Oregon.

CMS data shows 288 Medicare services from Dr. Ehst across 7 procedure codes in 2024, for 80 Medicare patients. Medicare paid $14,005 for them. Every service was in an office.

CMS counts 80 Medicare patients who saw Dr. Ehst in 2024. The largest group is 65 to 74, with 35 patients. 61% of them have high cholesterol, and 53% have high blood pressure. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ehst's median patient age at 62, with 45% women.

In 2024, Dr. Ehst wrote 211 Medicare Part D claims for 66 patients. 82% of them were for generic drugs. CMS names the drug for 95 of them, across 6 drugs with 11 or more claims each, at $553,737 in total drug cost. In 2023, CMS named 74 claims across 5 drugs.

Dr. Ehst accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 69 procedures of removal of skin lesions by Dr. Ehst, more than 73% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Ehst, published from 2012 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Psoriasis, Anti-Bacterial Agents and Biological Products. Dr. Ehst has published most often in J Am Acad Dermatol. Dr. Ehst's most frequent co-authors are Andrew Blauvelt, MD, Michael John Mauro, MD and Alex G. Ortega Loayza, MD.

Dmand AI links Dr. Ehst to 1 clinical trial. Conditions studied include Dermatitis, Atopic and Skin Diseases, Eczematous. Open Payments lists research payments to Dr. Ehst that name 3 trials.

CMS Open Payments shows 2,124 general payments to Dr. Ehst from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Eli Lilly and Company paid the most, $512,400. It also lists 17 research payments totaling $4,289 from 2018 to 2024, naming 3 clinical trials.

Dr. Ehst graduated from University of Minnesota Medical School in 2003.